Sorrento Therapeutics CEO on focusing on ‘the real deal’ antibody test rather than stock performance

Sorrento Therapeutics CEO on focusing on ‘the real deal’ antibody test rather than stock performanceYahoo Finance’s Alexis Christoforous and Brian Sozzi speak with Sorrento Therapeutics Founder & CEO Dr. Henry Ji about the company’s experimental antibody STI-1499.

from Yahoo Finance https://ift.tt/36hOAzs

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *